Sang No Lee

Title: Sang No Lee - Innovator in Pharmaceutical Composition

Introduction

Sang No Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at preventing or treating cognitive impairment-related diseases. His innovative approach has the potential to enhance patient care and treatment efficacy.

Latest Patents

Sang No Lee holds a patent for a method of preparing a pharmaceutical composition designed to prevent or treat cognitive impairment-related diseases. The patent describes a composition that includes microparticles containing donepezil and a biodegradable polymer. This formulation allows for a single injection to maintain its therapeutic effect for up to one month, thereby alleviating the need for daily administration. The design of the microparticles ensures that donepezil is uniformly distributed within a spherical biodegradable polymer, which minimizes discomfort during injection.

Career Highlights

Sang No Lee is associated with Inventage Lab Inc., where he continues to work on innovative solutions in the pharmaceutical sector. His research focuses on improving the delivery and effectiveness of treatments for cognitive impairments, showcasing his commitment to advancing medical science.

Collaborations

Sang No Lee collaborates with Ju Hee Kim, contributing to the development of groundbreaking pharmaceutical technologies. Their partnership exemplifies the collaborative spirit essential for innovation in the research and development field.

Conclusion

Sang No Lee's work in pharmaceutical compositions represents a significant advancement in the treatment of cognitive impairment-related diseases. His innovative methods and dedication to improving patient care highlight the importance of research and development in the pharmaceutical industry.